Premium
Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis
Author(s) -
Gooderham M.,
Elewski B.E.,
Pariser D.M.,
Sofen H.,
Mendelsohn A.M.,
Rozzo S.J.,
Li Q.
Publication year - 2019
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.15643
Subject(s) - medicine , psoriasis , incidence (geometry) , exacerbation , placebo , inflammatory bowel disease , gastroenterology , ixekizumab , psoriasis area and severity index , adverse effect , ulcerative colitis , dermatology , secukinumab , disease , psoriatic arthritis , pathology , physics , alternative medicine , optics